Tag Archives: rutgers-robert

15-year overall survival benefit lacking in older men treated with hormone therapy for early-stage prostate cancer — ScienceDaily

The research utilized information from 66,717 Medicare patients aged 66 and older diagnosed with clinical stage T1-T2 prostate cancer (cancer that did not spread beyond the prostate) between 1992 and 2009. These men did not have surgery or radiation treatment within six months of their diagnosis. The data were compiled from the population-based Surveillance, Epidemiology, and End Results (SEER) database linked to Medicare files. Grace Lu-Yao, PhD, MPH cancer epidemiologist at the Cancer Institute of New Jersey and professor of medicine at Rutgers Robert Wood Johnson Medical School, is the lead author…